i2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological drugs, announced today it has raised a $4 million seed funding round led by Sanofi Ventures and JDRF T1D Fund.


AccelFoods is an early-stage venture fund investing in consumer products. 
We partner with entrepreneurs to bring innovative, high-quality food and 
beverage products to the forefront of the industry and create the next 
generation of enduring brands. With nearly $40m under management, we are 
hands-on partners that work tactically with our founders to scale their 
businesses quickly and smartly. We connect the dots within the broader food 
& beverage ecosystem to provide unique access, share distinct expertise, 
and build solid infrastructure.

i2O Therapeutics Raises $4 million in Seed Funding Co-led by Sanofi Ventures and JDRF T1D Fund

Description

Company Information

Related People

i2O Therapeutics Raises $4 million in Seed Funding Co-led by Sanofi Ventures and JDRF T1D Fund

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information